Clinical Trial Update: Study for Hyalobarrier to Evaluate Anti-adhesive Effect and Safety Compared to Guardix-SG After Thyroidectomy [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating Hyalobarrier versus Guardix-SG for anti-adhesive effects after thyroidectomy has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Thyroid Disease

Drugs mentioned

• Guardix-SG
• Hyalobarrier

Snippet

Sponsor: Green Cross Corporation | Conditions: Thyroid Disease | Phase 3 | Status: COMPLETED